Elutia Confirms No Material Impact from Global Tariffs

Stock Information for Elutia Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Elutia Inc.

Elutia Announces Strong First Quarter 2025 Financial Results Driven by 84% Sequential Growth in EluPro(TM) Sales
Elutia Transitions to Direct Distribution of Its Cardiovascular Product Portfolio
Elutia to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025
Elutia to Participate in Chardan's Trending Issues in Drug Development Conference Series on April 29
Elutia Initiates EluPro(TM) Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical Practice
EluPro(TM) Named as 2025 Edison Award Winner
Elutia to Participate in Upcoming Investor Conferences
Elutia to Debut EluPro(TM) at HRS 2025 - Experience the Difference Biology Makes

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.